Related Experiment Video
Updated: Apr 14, 2026

Introducing a Gene Knockout Directly Into the Amastigote Stage of Trypanosoma cruzi Using the CRISPR/Cas9 System
Published on: July 31, 2019
Inducible suicide vector systems for Trypanosoma cruzi
Yanfen Ma1, Louis M Weiss2, Huan Huang1
1Department of Pathology, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Researchers developed a novel inducible system for Trypanosoma cruzi, the parasite causing Chagas disease. This system allows for controlled parasite death, aiding research and creating safer, attenuated vaccines against infection.
Area of Science:
- Parasitology
- Tropical Medicine
- Vaccine Development
Background:
- Chagas disease, caused by Trypanosoma cruzi, is a significant neglected tropical disease with poorly understood pathogenesis and no effective vaccine.
- Live attenuated vaccines offer protection but raise concerns regarding latent infection or virulence reversion.
Purpose of the Study:
- To establish an inducible system for Trypanosoma cruzi to induce parasite death.
- To develop a novel, safe live attenuated vaccine strategy against Chagas disease.
Main Methods:
- Engineered inducible systems in T. cruzi using the Escherichia coli dihydrofolate reductase (ecDHFR) degradation domain (DDD).
- Expressed toxic proteins (Alpha-toxin, Cecropin A, GFP) fused to DDD with a hemagglutinin tag (HA) in T. cruzi amastigotes.
- Assessed inducible cell death and protective efficacy in mouse models.
Main Results:
- Inducible expression of DDDHA fusions, including Alpha-toxin-DDDHA and Cecropin A-DDDHA, led to amastigote cell death.
- Engineered T. cruzi strains were attenuated in mice, showing no pathological changes.
- Inoculation with these attenuated strains conferred strong protection against lethal wild-type T. cruzi infection.
Conclusions:
- The developed inducible system effectively induces Trypanosoma cruzi death, offering a tool for studying parasite biology.
- This technology provides a promising foundation for designing safe and effective live attenuated vaccines against Chagas disease.
More Related Videos
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
10:13An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
Published on: January 12, 2018